{
    "Trade/Device Name(s)": [
        "Rightest Blood Glucose Monitoring System, Model GM110"
    ],
    "Submitter Information": "Bionime Corporation",
    "510(k) Number": "K081450",
    "Predicate Device Reference 510(k) Number(s)": [
        "K042678",
        "K053635",
        "K062567"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA"
    ],
    "Summary Letter Date": "August 15, 2008",
    "Summary Letter Received Date": "August 18, 2008",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Rightest Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometry"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strips",
        "Control Solution",
        "Lancing Device",
        "Lancets"
    ],
    "Document Summary": "FDA 510(k) summary for Rightest Blood Glucose Monitoring System, Model GM110 measuring glucose in capillary whole blood for diabetes management",
    "Indications for Use Summary": "Intended for in vitro diagnostic use by healthcare professionals or diabetics at home to measure glucose in capillary whole blood from fingertip, palm, and forearm to aid diabetes management; not for neonatal samples",
    "fda_folder": "Clinical Chemistry"
}